Robert S. Epstein - 01 Oct 2025 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Reporting relationship: Director
Issuer ticker: VCYT
Reported as of: 01 Oct 2025
Net transaction value: -$673,804
SEC form: 4
Accepted by SEC: 03 Oct 2025, 16:16:18 UTC
Prior SEC filing: 23 Jun 2025
Next SEC filing: 06 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Wygant, as attorney-in-fact

Filing notes and source

Key filing fact

Robert S. Epstein filed Form 4 for VERACYTE, INC. (VCYT) on 03 Oct 2025.

Key facts

This page summarizes Robert S. Epstein's Form 4 filing for VERACYTE, INC. (VCYT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Oct 2025, 16:16.

Change

Previous filing in this sequence was filed on 23 Jun 2025.
Current net transaction value: -$673,804.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001252004 Primary reporting owner

EPSTEIN ROBERT S

Relationship: Director
Address: 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO
Signature: /s/ Jonathan Wygant, as attorney-in-fact
Signature date: 03 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCYT transaction

Common Stock

Options Exercise

Transaction value: $79,400
Shares: +10,000
Change %: +14%
Price: $7.94
Shares after: 83,919
Date: 01 Oct 2025
Ownership: Direct
Footnotes: F1

VCYT transaction

Common Stock

Sale

Transaction value: $753,204
Shares: -21,473
Change %: -26%
Price: $35.08
Shares after: 62,446
Date: 01 Oct 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCYT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -10,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $7.94
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 5, 2025.

Footnote F2

Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.